10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001493152-22-008324`
Period End Date	20211231
Filing Date	20220331
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 39 Cash Flow Statement 82 Stockholders Equity 17

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.50M	USD	Point-in-time
Marketable securities	`DebtSecurities`	$16.18M	USD	Point-in-time
Marketable securities	`DebtSecurities`	$501.00K	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.09M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.64M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$34.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$184.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$304.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$40.31M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.47M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.05M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$149.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$179.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.99M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.15M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.97M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.15M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.15M	shares	Point-in-time
Marketable securities, long term	`MarketableSecuritiesNoncurrent`	$15.38M	USD	Point-in-time
Marketable securities, long term	`MarketableSecuritiesNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.99M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$748.00K	USD	Point-in-time
Total assets	`Assets`	$64.58M	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$383.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$198.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$438.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$442.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$47.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$37.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$230.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$673.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.10M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$132.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$112.00K	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 17)	`LongTermDebtNoncurrent`	$1.88M	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 17)	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$35.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$180.00K	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, 13, and 17)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, issued and outstanding 715 and 732, respectively	`PreferredStockValue`	$715.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, issued and outstanding 715 and 732, respectively	`PreferredStockValue`	$732.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 47,994,672 and 42,154,371, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 47,994,672 and 42,154,371, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$402.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$417.22M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-47.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-341.97M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$61.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$13.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$64.58M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$135.00K	USD	Annual
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$163.00K	USD	Annual
Production costs	`ManufacturingCosts`	$806.00K	USD	Annual
Production costs	`ManufacturingCosts`	$850.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.72M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.67M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$8.65M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$8.67M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$1.78M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$135.00K	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$1.78M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$18.97M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$15.31M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-15.15M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-18.84M	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$219.00K	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$-201.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	$67.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	$672.00K	USD	Annual
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	$-2.70M	USD	Annual
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	$142.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$216.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$123.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-145.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-2.32M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.19M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.13M	USD	Annual
Net Loss	`NetIncomeLoss`	$-14.40M	USD	Annual
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	$376.00K	USD	Annual
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	-	USD	Annual
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-329.00K	USD	Annual
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-47.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.45M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.08M	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.45	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	47.34M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.84M	shares	Annual

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-19.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.40M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$659.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$665.00K	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$123.00K	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-145.00K	USD	Annual
Abandonment of patents and trademarks	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	Annual
Abandonment of patents and trademarks	`ImpairmentOfIntangibleAssetsFinitelived`	$158.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$216.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Allowance for bad debt recovery	`AllowanceForLoanAndLeaseLossRecoveryOfBadDebts`	-	USD	Annual
Allowance for bad debt recovery	`AllowanceForLoanAndLeaseLossRecoveryOfBadDebts`	$30.00K	USD	Annual
Warrant modification	`WarrantModification`	-	USD	Annual
Warrant modification	`WarrantModification`	$46.00K	USD	Annual
Extinguishment of financing obligation and note payable	`ExtinguishmentOfFinancingObligationAndNotePayables`	$2.70M	USD	Annual
Extinguishment of financing obligation and note payable	`ExtinguishmentOfFinancingObligationAndNotePayables`	$142.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$116.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$68.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$30.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$-27.00K	USD	Annual
Inventory write-off	`InventoryWriteDown`	-	USD	Annual
Inventory write-off	`InventoryWriteDown`	$1.09M	USD	Annual
Impairment of plant property equipment and other assets	`OtherAssetImpairmentCharges`	$135.00K	USD	Annual
Impairment of plant property equipment and other assets	`OtherAssetImpairmentCharges`	$1.78M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-2.32M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-96.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$1.57M	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$1.04M	USD	Annual
Realized gain (loss) on sale of marketable securities	`DebtSecuritiesAvailableForSaleGainLoss`	-	USD	Annual
Realized gain (loss) on sale of marketable securities	`DebtSecuritiesAvailableForSaleGainLoss`	$-47.00K	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$47.00K	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$112.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-34.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-40.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInOtherReceivables`	$314.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInOtherReceivables`	$551.00K	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.63M	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-671.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-30.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$27.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-185.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-89.00K	USD	Annual
Accrued interest expense	`IncreaseDecreaseInInterestPayableNet`	$231.00K	USD	Annual
Accrued interest expense	`IncreaseDecreaseInInterestPayableNet`	-	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$39.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.37M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.96M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.04M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.29M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$18.61M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$22.54M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$41.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$245.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$573.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$592.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-631.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.16M	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	$355.00K	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	$122.00K	USD	Annual
Payoff of note payable	`RepaymentsOfNotesPayable`	$4.33M	USD	Annual
Payoff of note payable	`RepaymentsOfNotesPayable`	$4.73M	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$61.25M	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$13.04M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.19M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$56.56M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.41M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.03M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Stock issued to settle accounts payable	`StockIssued1`	$15.00K	USD	Annual
Stock issued to settle accounts payable	`StockIssued1`	$55.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$17.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$46.00K	USD	Annual
Operating Lease - Right of Use Assets	`OperatingLeaseRightOfUseAssets`	$18.00K	USD	Annual
Operating Lease - Right of Use Assets	`OperatingLeaseRightOfUseAssets`	$66.00K	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$13.44M	USD	Point-in-time
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$13.04M	USD	Annual
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$61.25M	USD	Annual
Warrant modification	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$46.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.57M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.04M	USD	Annual
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$15.00K	USD	Annual
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$55.00K	USD	Annual
Series B preferred shares converted to Common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$-46.00K	USD	Annual
Series B preferred shares converted to Common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.45M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.08M	USD	Annual
Ending balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$13.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.